Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease

Renal Failure

Volumn 33, Issue 2, 2011, Pages 131-137

  Kratochvilová, Markéta ^a   Zakiyanov, Oskar ^a   Kalousová, Marta ^a   Kříha, Vítězslav ^b   Zima, Tomáš ^a   Tesař, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

advanced glycation end products; anemia; atherosclerosis; chronic kidney disease; nutrition

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; HEMOGLOBIN; OROSOMUCOID; PREALBUMIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBINS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREALBUMIN; RENAL INSUFFICIENCY, CHRONIC;

EID: 79951992162     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.541581     Document Type: Article

References (40)

1. Siems W, Quast S, Carluccio F, et al. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol. 2002;58(Suppl. 1):S12-S19.
2. Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899-1911. (Pubitemid 29197978)
3. Brownlee M. Advanced glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223-234.
4. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271: 9982-9986.
5. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582-592. (Pubitemid 39078671)
6. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol. 2005;289:F645-F659. (Pubitemid 41324185)
7. Daroux M, Prévost G, Maillard-Lefebvre H, et al. Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 2010;36:1-10.
8. Hartog JW, Smit AJ, van Son WJ, et al. Advanced glycation end products in kidney transplant patients: A putative role in the development of chronic renal transplant dysfunction. Am J Kidney Dis. 2004;43:966-975. (Pubitemid 38691491)
9. Berrou J, Tostivint I, Verrecchia F, et al. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int J Mol Med. 2009;23:513-520.
10. Halliwell B. The role of oxygen radicals in human disease with particular reference to vascular system. Hemostasis. 1993;23 (Suppl. 1):118-126. (Pubitemid 23116285)
11. Boosalis MG, Snowdon DA, Tully CL, Gross MD. Acute phase response and plasma carotenoid concentrations in older women: Findings from the nun study. Nutrition. 1996 Jul-Aug; 12(7-8):475-478. (Pubitemid 26299984)
12. Henle T, Deppisch R, Beck W, Hergesell O, Hänsch GM, Ritz E. Advanced glycated end-products (AGE) during hemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant. 1999;14:1968-1975. (Pubitemid 29358896)
13. Münch G, Keis R, Wessels A, et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem. 1997;35:669-677.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
15. Riella MC. Malnutrition in dialysis: Malnourishment or uremic inflammatory response? Kidney Int. 2000;57:1211-1232. (Pubitemid 30434815)
16. Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E. Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant. 2001;16:776-782. (Pubitemid 32257975)
17. Jansen MA, Korevaar JC, Dekker FW, et al. Renal function and nutritional status at the start of chronic dialysis treatment. J Am Soc Nephrol. 2001;12:157-163. (Pubitemid 32056801)
18. Wautier JL, Schmidt AM. Protein glycation: A firm link to endothelial cell dysfunction. Circ Res. 2004;95:233-238. (Pubitemid 39056283)
19. Horie K, Miyata T, Maeda K, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1997;100:2995-3004. (Pubitemid 28022836)
20. Yamada K, Miyahara Y, Hamaguchi K, et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol. 1994;42:354-361.
21. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A. 1994;91:11704-11708. (Pubitemid 24356413)
22. Gugliucci A, Bendayan M. Reaction of advanced glycation endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: An ultrastructural study using colloidal gold cytochemistry. J Histochem Cytochem. 1995;43: 591-600.
23. Semba RD, Ferrucci L, Fink JC, et al. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am J Kidney Dis. 2009;53:51-58.
24. Kilhovd BK, Juutilainen A, Lehto S, et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in non-diabetic men: A population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol. 2005;25:815-820. (Pubitemid 40463875)
25. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 1994;46:216-222. (Pubitemid 24210454)
26. Makita Z, Bucala R, Rayfield EJ, et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet. 1994;343:1519-1522. (Pubitemid 24180047)
27. Vlassara H. Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif. 1994;12:54-59. (Pubitemid 24242711)
28. Kalousová M, Zima T, Tesar V, et al. Glycoxidation in hemodialyzed patients with diabetes mellitus. In: Timio M, Wiyemann V, Venanzi, eds. Cardionephrology. Vol. 7. Cosenza, Italy: Editoriale Bios; 2002:297-300.
29. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int. 1998;54: 1290-1295. (Pubitemid 28449917)
30. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999;55:389-399.
31. Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int. 2002;62:301-310. (Pubitemid 34754076)
32. Wagner Z, Molnár M, Molnár GA, et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:294-300. (Pubitemid 43121332)
33. Teplan V, Vyhnálek F, Gürlich R, et al. Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr. 2010; 122(15-16):466-473.
34. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953-960. (Pubitemid 30410364)
35. Romão JE Jr, Haiashi AR, Elias RM, et al. Positive acutephase inflammatory markers in different stages of chronic kidney disease. Am J Nephrol. 2006;26:59-66.
36. Kalousová M, Sulková S, Fialová L, et al. Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant. 2003;18:2577-2581. (Pubitemid 37483791)
37. Thomas MC, Tsalamandris C, MacIsaac R, et al. Lowmolecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int. 2004;66:1167-1172. (Pubitemid 39121024)
38. Holland DC, Lam M. Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study. Nephrol Dial Transplant. 2000;15:650-658. (Pubitemid 30242983)
39. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol. 2002;13:1928-1936. (Pubitemid 34700619)
40. Forbes JM, Thorpe SR, Thallas-Bonke V, et al. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol. 2005;16:2363-2372. (Pubitemid 41725054)